Clarius Group, LLC Abb Vie Inc. Transaction History

Clarius Group, LLC

$1.4 Billion
Q3 2024

A detailed history of Clarius Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 16,251 shares of ABBV stock, worth $2.93 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

16,251

Previous 16,686 2.61%

Holding current value

$2.93 Million

Previous $2.86 Million 12.16%

% of portfolio

0.23%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$163.84 - $199.33 $71,270 - $86,708	-435 Reduced 2.61%	16,251 $3.21 Million
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $73,060 - $85,318	-472 Reduced 2.75%	16,686 $2.86 Million
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $282,721 - $322,134	-1,769 Reduced 9.35%	17,158 $3.12 Million
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $465,225 - $523,953	3,381 Added 21.75%	18,927 $2.93 Million
Q3 2023 Oct 19, 2023	SELL	$133.59 - $154.65 $593,006 - $686,491	-4,439 Reduced 22.21%	15,546 $2.32 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $27,297 - $33,969	206 Added 1.04%	19,985 $2.69 Million
Q1 2023 Apr 17, 2023	BUY	$144.61 - $166.54 $87,922 - $101,256	608 Added 3.17%	19,779 $3.15 Million
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $32,917 - $39,477	238 Added 1.26%	19,171 $3.1 Million
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $62,139 - $71,269	463 Added 2.51%	18,933 $2.54 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $78,856 - $100,252	573 Added 3.2%	18,470 $2.83 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $42,434 - $53,692	395 Added 2.26%	17,897 $2.42 Million
Q3 2021 Oct 18, 2021	BUY	$106.4 - $120.78 $44,475 - $50,486	418 Added 2.45%	17,502 $1.89 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $21,252 - $23,676	202 Added 1.2%	17,084 $1.92 Million
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $183,014 - $201,477	1,789 Added 11.85%	16,882 $1.83 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $108,017 - $145,835	1,342 Added 9.76%	15,093 $1.62 Million
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $10,996 - $12,906	-128 Reduced 0.92%	13,751 $1.2 Million
Q2 2020 Jul 08, 2020	BUY	$73.37 - $98.18 $280,566 - $375,440	3,824 Added 38.03%	13,879 $1.36 Million
Q1 2020 Apr 24, 2020	BUY	$64.5 - $97.79 $19,092 - $28,945	296 Added 3.03%	10,055 $766,000
Q4 2019 Jan 22, 2020	BUY	$72.13 - $90.25 $57,776 - $72,290	801 Added 8.94%	9,759 $871,000
Q3 2019 Oct 23, 2019	SELL	$62.98 - $75.72 $48,935 - $58,834	-777 Reduced 7.98%	8,958 $678,000
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $325,083 - $415,533	4,948 Added 103.36%	9,735 $708,000
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $66,571 - $78,351	863 Added 21.99%	4,787 $386,000
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $77,694 - $95,817	998 Added 34.11%	3,924 $362,000
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $260,150 - $289,205	2,926 New	2,926 $277,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Abb Vie Inc. Transaction History